Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis (Q36304339)

13 August 2017

1 reference

title

Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis (English)

1 reference

13 August 2017

0 references

1 reference

Robin P Choudhury

1

1 reference

13 August 2017

Justin M Lee

series ordinal

2

1 reference

13 August 2017

David R Greaves

series ordinal

3

1 reference

13 August 2017

1 June 2005

1 reference

Nature Clinical Practice Cardiovascular Medicine

13 August 2017

1 reference

13 August 2017

2

1 reference

13 August 2017

6

1 reference

13 August 2017

309-315

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpcardio0195

13 August 2017

0 references

cites work

The response-to-retention hypothesis of early atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

The macrophage foam cell as a target for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: the Ludwigshafen Risk and Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Novel effects of the acyl-coenzyme A:Cholesterol acyltransferase inhibitor 58-035 on foam cell development in primary human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

A potent synthetic LXR agonist is more effective than cholesterol loading at inducing ABCA1 mRNA and stimulating cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Peroxisome proliferator-activated receptor alpha reduces cholesterol esterification in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Statin therapy: beyond cholesterol lowering and antiinflammatory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

In vivo temperature heterogeneity of atherosclerotic plaques is determined by plaque composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

7 January 2021

Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

7 January 2021

Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

7 January 2021

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

7 January 2021

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

7 January 2021

Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

7 January 2021

Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

7 January 2021

Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

7 January 2021

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

7 January 2021

Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

7 January 2021

Effect of the acyl-CoA:cholesterol acyltransferase inhibitor, E5324, on experimental atherosclerosis in rabbits

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

7 January 2021

Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

7 January 2021

High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

7 January 2021

PPARs as Therapeutic Targets: Reverse Cardiology?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

7 January 2021

Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

7 January 2021

Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0195

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO0195

1 reference

Dimensions Publication ID

13 August 2017

0 references

1 reference